Posts

ESJ Comment: Long-Term Outcome After Ischemic Stroke in Relation to Comorbidity

[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…

Market Launch of First Factor Xa Reversal Agent in European Countries

[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…

FESO Interview with Christine Kremer

[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…

Department to Department Visit Programme Report by Guiseppe Reale

[et_pb_section bb_built="1"][et_pb_row][et_pb_column type="1_3"][et_pb_image…

ESO-Karolinska Stroke Update Conference 2018

[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…